» Articles » PMID: 38796285

Merkel-cell Carcinoma: ESMO-EURACAN Clinical Practice Guideline for Diagnosis, Treatment and Follow-up

Overview
Journal ESMO Open
Publisher Elsevier
Specialty Oncology
Date 2024 May 25
PMID 38796285
Authors
Affiliations
Soon will be listed here.
References
1.
DArcy M, Castenson D, Lynch C, Kahn A, Morton L, Shiels M . Risk of Rare Cancers Among Solid Organ Transplant Recipients. J Natl Cancer Inst. 2020; 113(2):199-207. PMC: 7850530. DOI: 10.1093/jnci/djaa078. View

2.
Dykewicz C . Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. Clin Infect Dis. 2001; 33(2):139-44. DOI: 10.1086/321805. View

3.
Zitvogel L, Kroemer G . Targeting PD-1/PD-L1 interactions for cancer immunotherapy. Oncoimmunology. 2012; 1(8):1223-1225. PMC: 3518493. DOI: 10.4161/onci.21335. View

4.
Sauer C, Haugg A, Chteinberg E, Rennspiess D, Winnepenninckx V, Speel E . Reviewing the current evidence supporting early B-cells as the cellular origin of Merkel cell carcinoma. Crit Rev Oncol Hematol. 2017; 116:99-105. DOI: 10.1016/j.critrevonc.2017.05.009. View

5.
Morton D, Cochran A, Thompson J, Elashoff R, Essner R, Glass E . Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005; 242(3):302-11. PMC: 1357739. DOI: 10.1097/01.sla.0000181092.50141.fa. View